Home  >  News
  Pacira Pharma phase 4 study of Exparel in patients undergoing C-section achieves primary endpoint with significant reductions in opioid consumption,   January 19, 2019
  Isofol announces positive results from phase 1/2a open label extension study with arfolitixorin in patients with mCRC,   January 19, 2019
  AIVITA Biomedical receives US FDA approval to initiate phase 1B melanoma trial,   January 18, 2019
  Innovent begins patient dosing in phase III trial of anti-PD-1 antibody Tyvyt to treat advanced gastric cancer,   January 18, 2019
  GSK, MMV announce publication of positive results from two phase III studies of tafenoquine for radical cure of P. vivax malaria in NEJM,   January 18, 2019
  Inovio's dMAb PD-1 checkpoint inhibitors demonstrate higher and more prolonged expression compared to native -pembrolizumab and nivolumab sequences in preclinical studies,   January 17, 2019
  Sound Pharmaceuticals advances Phase 2 hearing loss clinical trial in Cystic Fibrosis,   January 16, 2019
  Array BioPharma to present results from phase 3 BEACON CRC trial of combo Braftovi, Mektovi & Erbitux in mCRC at ASCO 2019 symposium,   January 16, 2019
  Research consortium begins patient enrollment in clinical trial examining fecal microbiota transplant for recurrent diarrheal disease,   January 16, 2019
  Innovent begins phase I trial of anti-CD47 monoclonal antibody, IB1188 to treat patients with advanced malignancies,   January 16, 2019
  Daiichi Sankyo begins DESTINY-Breast04 phase 3 trial of [Fam-] trastuzumab deruxtecan in HER2 low metastatic breast cancer,   January 16, 2019
  Eisai to present abstracts from phase 3 REFLECT trial of Lenvima in unresectable HCC at 2019 Gastrointestinal Cancers Symposium,   January 15, 2019
  Verona Pharma reports data from 3-day phase 2 trial evaluating nebulized ensifentrine,   January 15, 2019
  BioFluidica gets US$ 1.7 million NIH grant for clinical trial in children with acute lymphoblastic leukemia,   January 14, 2019
  HVIVO announces positive results from phase IIb viral challenge study of FLU-v in mild to moderate influenza,   January 12, 2019
  Acceleron announces publication of luspatercept phase 2 beta-thalassemia study results in Blood,   January 12, 2019
  Vast Therapeutics' drug candidate, BIOC51 is active against Bacillus anthracis, commonly known as anthrax,   January 11, 2019
  IRRAS successfully treats first patient in US with IRRAflow,   January 11, 2019
  Cellular Biomedicine begins patient recruitment in clinical trial of anti-BCMA CART-T therapy targeting multiple myeloma,   January 10, 2019
  Baxter begins clinical trial for on-demand peritoneal dialysis solution system in US,   January 09, 2019

Copyright © 2016 Saffron Media Pvt. Ltd |